Purchase Order 75F40126P00327
- Not listed
- The Food and Drug Administration awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for a multiparameter flow cytometric cell sorter with spectral analysis and cell imaging on July 31, 2023, with a firm fixed price ceiling of $750,244.75 and an ultimate completion date of October 29, 2023. Place of performance is San Jose, California. The equipment is intended for the FDA's Center for Biologics Evaluation and Research at its White Oak facility and includes...
- The Food and Drug Administration awarded a purchase order to Cell Microsystems Inc. for $52,550.00 on July 6, 2026, to procure a BioFlux 200+ flexible shear flow system under a Total Small Business set-aside. The equipment will be delivered to Durham, North Carolina and is intended for the FDA's Laboratory of Cellular Hematology to evaluate human platelets and red blood cells in physiological environments. The system must be new, capable of delivering shear flow rates from 0 to 200 dynes/cm²,...
- <p>The Food and Drug Administration issued a $154,840.80 delivery order to Becton, Dickinson And Company on September 8, 2025, for preventive maintenance and repair services on a Becton Dickinson FACSAria Illu flow cytometer/cell sorter (4-laser system).</p> <p>The order is issued under the General Services Administration Multiple Award Schedule. Place of performance is Jefferson, AR. The order runs through September 7, 2030, and is priced on a firm fixed-price basis with no set-aside.</p>
- <p>The Office of Naval Research awarded a purchase order to SBT Instruments A/S for $16,802.00 on December 23, 2024. The order procures BACTOBOX equipment with a firm fixed price and place of performance in Washington, DC. Ultimate completion is scheduled for January 24, 2025.</p>
- The Department of Health and Human Services Food and Drug Administration awarded a $660,504 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a FACSYMPHONY A5 SE flow cytometer with spectral analysis capabilities and annual maintenance options. The solicitation sought a multiparameter flow cytometric analyzer meeting minimum requirements including specific lasers, emission optics, and variable sample handling capabilities for...
- <p>The Food and Drug Administration issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on May 13, 2022, with a ceiling value of $64,908 for FACSCANTO II system flow cytometer service, to be completed by August 27, 2027.</p> <p>The order is issued under the GSA Multiple Award Schedule (MAS). Place of performance is Jefferson, AR. The order carries firm fixed pricing and was issued without set-aside.</p>
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for the provision of a high performance flow cytometer and associated accessories and service maintenance. The contract, valued at $366,977.00, does not have a set-aside designation, indicating that it was awarded on a full and open competition basis. BD, a global medical technology company, is the prime contractor for this award, which supports the FDA's...
- <p>The Food and Drug Administration issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on April 17, 2024, for preventive maintenance and repair services for a BD 4-Laser LSR Fortessa Flow Cytometer flow cytometry instrument system, with a ceiling value of $133,465.20.</p> <p>Place of performance is Jefferson, AR 72079. The order runs through July 21, 2029. Work is priced on a firm fixed price basis and carries no set-aside designation.</p>
- The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
- <p>The Food and Drug Administration awarded a purchase order to Life Technologies Corporation for an Attune NXT with Autosampler flow cytometer service agreement valued at $11,904.16, with an award date of January 13, 2022. The order was closed out on January 12, 2024, with excess funds de-obligated as part of the final modification. Place of performance is Silver Spring, Maryland. The contract is firm fixed price with no set-aside applied.</p>
The Food and Drug Administration awarded a purchase order to SBT Instruments A / S for $23,746.00 on September 14, 2026, for one BactoBox cell enumerator (bacterial flow cytometer) instrument under a Total Small Business set-aside. Place of performance is Denmark, with FOB Destination delivery to the Carlson Lab at FDA's Silver Spring, Maryland facility. The instrument must deliver rapid sample assessment in less than five minutes per sample, a 2-log linear range, viable/intact bacterial cell enumeration capability, portable benchtop design, data visualization and analysis software, dilution dispenser, flow cells, and consumables supporting 200 runs. The award includes a minimum one-year full manufacturer's warranty with unlimited telephone and email support. Ultimate completion date is October 15, 2026. Pricing is firm fixed-price; the underlying solicitation was posted August 26, 2026 and closed September 1, 2026.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
FDA Cell Enumerator (BactoBox or equal) | 75F40126Q134234 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 8/26/26, 11:22 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 9/15/26 |